Form D · Other Health Care
Eyevensys S.A.S.
Paris, I0 · CIK 0001884944
Offering snapshot reported Sep 29, 2021 · SEC filing
- Reported sold
- $10M Offering amount: $46.5M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Aug 2, 2021 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Sep 29, 2021 | Initial | $10,000,000 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Equity, Option to acquire
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $280K
- Finders' fees
- $0
- Form D file number
- 021-414975
The Total Offering Amount and Total Amount Sold are in EURO.
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| Wedbush Securities Inc. | 877 |
Source: Form D, filed Sep 29, 2021. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Francine Behar Cohen | Executive, Promoter |
| Thierry Bordet | Executive |
| Ronald Buggage | Executive |
| Patricia Zilliox | Director, Executive, Promoter |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
Biopark Bat B 11 Rue Watt
Paris, I0, 75013
Paris, I0, 75013